Main Story
-

From One Man's Vision to a Shared Dream: Somaiya Vidyavihar University Opens the 2026 FISU World University Championship Squash
Every institution has defining moments, but the ones that leave a lasting legacy are shaped by a vision carried forward across generations. Long before athletes from 14 nations arrived in Mumbai for the 2026 FISU World University Championship Squash, Shri K J Somaiya believed education should create opportunities that extended beyond the classroom. That belief…
Products
-
AccuSure AS9 Fully Automatic Digital Blood Pressure Monitor With Large Display
Original price was: ₹1,733.00.₹998.00Current price is: ₹998.00. -
AGEasy Max Group Fully Automatic One Touch Digital Blood Pressure Monitoring Device
Original price was: ₹1,405.00.₹949.00Current price is: ₹949.00. -
Automatic Digital Blood Pressure Monitor for Upper Arm, Large LCD Display
Original price was: ₹2,399.00.₹448.00Current price is: ₹448.00. -
Beurer German Engineering P0 13 Kid’s Pulse Oximeter I Fingertip Home Pulse Oximeter
Original price was: ₹2,745.00.₹1,538.00Current price is: ₹1,538.00. -
BPL Medical Technologies Bluetooth Enabled Arm Type Blood Pressure Monitor
Original price was: ₹6,563.00.₹5,199.00Current price is: ₹5,199.00.
Automobile
Tech
Entertainment
Health
-
Avicanna Reports Q2 2026 Financial Results
Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product salesQUIX™ rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured Source: Avicanna Reports Q2 2026 Financial Results
-

More Cancer Patients Are Opting to Preserve Their Tumors
New Tumor-Preservation Service Opens in Arizona, Giving Patients the Chance to Preserve Tumor Tissue for Potential Personalized Dendritic Cell Therapy Source: More Cancer Patients Are Opting to Preserve Their Tumors
-
Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update
SAN DIEGO, Aug. 12, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its financial results for the second quarter ended June 30, 2026, and provided a business…
-
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares Source: FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.




























